Skip Navigation


European Heart Journal Advance Access originally published online on September 1, 2005
European Heart Journal 2005 26(20):2075-2076; doi:10.1093/eurheartj/ehi475
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
26/20/2075    most recent
ehi475v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Crea, F.
Right arrow Articles by Andreotti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crea, F.
Right arrow Articles by Andreotti, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe?

Filippo Crea* and Felicita Andreotti

Institute of Cardiology, Catholic University, Rome 00168, Italy

* Corresponding author. Tel: +39 06 3051166. E-mail address: filippo.crea@rm.unicatt.it

This editorial refers to ‘Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris’{dagger} by J. Cosin-Sales et al., on page 2093

The first 10% of the full text of this article appears below.

The natural history of coronary artery disease is complex and is characterized by the central role played by inflammation. Atherogenic stimuli, such as oxidized lipoproteins, glycation end products, hypertension, and smoking, cause endothelial dysfunction and apoptosis, vascular expression of adhesion molecules, and recruitment of inflammatory cells, which then migrate in the intima, thus setting the stage for plaque formation.1 Coronary atherosclerotic plaques have a high prevalence in the population, even in subjects dying of non-cardiac causes, and their burden increases with age.2 In many subjects these plaques remain silent for life; in others they suddenly become thrombogenic, triggering occlusive or subocclusive thrombosis, responsible for acute coronary syndromes. In survivors of a first acute coronary event, the latter is followed by a period, lasting about . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris
Juan Cosin-Sales, Juan Carlos Kaski, Michael Christiansen, Paul Kaminski, Claus Oxvig, Michael T. Overgaard, Della Cole, and David W. Holt
EHJ 2005 26: 2093-2098. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Hum ReprodHome page
J. K. Ranta, K. Raatikainen, J. Romppanen, K. Pulkki, and S. Heinonen
Increased time-to-pregnancy and first trimester Down's syndrome screening
Hum. Reprod., November 26, 2009; (2009) dep417v1.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
C. Etter, Y. Straub, M. Hersberger, H. R. Raz, T. Kistler, D. Kiss, R. P. Wuthrich, H.-J. Gloor, D. Aerne, P. Wahl, et al.
Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis
Eur. Heart J., October 21, 2009; (2009) ehp429v1.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. Pellitero, J. L Reverter, M. L. Granada, E. Pizarro, M C. Pastor, D. Tassies, J. C. Reverter, I. Salinas, and A. Sanmarti
Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the presence and the morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control
Eur. J. Endocrinol., June 1, 2009; 160(6): 925 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
C Joaquin, E Aguilera, M L Granada, M C Pastor, I Salinas, N Alonso, and A Sanmarti
Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.
Eur. J. Endocrinol., April 1, 2008; 158(4): 483 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Pellitero, J. L. Reverter, E. Pizarro, M. C. Pastor, M. L. Granada, D. Tassies, J.-C. Reverter, I. Salinas, and A. Sanmarti
Pregnancy-Associated Plasma Protein-A Levels Are Related to Glycemic Control but Not to Lipid Profile or Hemostatic Parameters in Type 2 Diabetes
Diabetes Care, December 1, 2007; 30(12): 3083 - 3085.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
J. C. Kaski and D. W. Holt
Pregnancy-associated plasma protein-A and cardiovascular risk
Eur. Heart J., July 2, 2006; 27(14): 1637 - 1639.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Mueller, B. Dieplinger, W. Poelz, and M. Haltmayer
Increased Pregnancy-Associated Plasma Protein-A as a Marker for Peripheral Atherosclerosis: Results from the Linz Peripheral Arterial Disease Study
Clin. Chem., June 1, 2006; 52(6): 1096 - 1103.
[Abstract] [Full Text] [PDF]